A Study to assess the safety, efficacy and tolerability of Rituximab(Mabthera) in combination with Plasma Exchange in patients with Acute Thrombotic Thrombocytopenia Purpura

Update Il y a 4 ans
Reference: EUCTR2005-002274-30

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Time to remission as defined by days until sustained platelet count>150 X 109/L, normal lactate dehydrogenase and number of plasma exchanges required, as defined by No of procedures per admission compared to historical controls.


Inclusion criteria

  • Thrombotic Thrombocytopenia Purpura

Links